PFBT
CSTL icon

Parkside Financial Bank & Trust’s Castle Biosciences CSTL Stock Holding History

Parkside Financial Bank & Trust’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$614 Hold
25
– – ﹤0.01% 2511
2025
Q4 		$973 Buy
+25
New +$806 ﹤0.01% 2356
2025
Q3 		– Sell
-25
Closed -$511 – 2734
2025
Q2 		$511 Buy
25
+5
+25% +$93 ﹤0.01% 2537
2025
Q1 		$401 Buy
+20
New +$495 ﹤0.01% 2536

Other funds holding CSTL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Parkside Financial Bank & Trust's CSTL Position: Q1 2026 in Review

Parkside Financial Bank & Trust held its Castle Biosciences (CSTL) position steady in Q1 2026 at 25 shares worth $614. The position accounts for ﹤0.01% of the portfolio, ranked #2511.

Parkside Financial Bank & Trust first reported a position in CSTL in Q1 2025 and has held it in 4 quarters since. The position peaked at $973 in Q4 2025. 186 funds tracked by Wall St. Rank hold CSTL as of Q1 2026.

  • Parkside Financial Bank & Trust held 25 shares of Castle Biosciences worth $614 as of Q1 2026.
  • Parkside Financial Bank & Trust left its Castle Biosciences share count unchanged in Q1 2026.
  • Castle Biosciences made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #2511 holding.
  • Parkside Financial Bank & Trust first reported a position in Castle Biosciences in Q1 2025 and has held it in 4 quarters since.
  • Parkside Financial Bank & Trust's Castle Biosciences position peaked at $973 in Q4 2025.
  • 186 funds tracked by Wall St. Rank held Castle Biosciences as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.